WHC is still in active development. Read this to understand our approach.
depiction of UVCOILFBWYKHHB-UHFFFAOYSA-N.svg
tripsit

norflurazepam

Verificar en tripsit

isomerdesign

Norflurazepam

Verificar en isomerdesign

wiki

N-Desalkylflurazepam

Verificar en wiki

Data

InChI: InChI=1S/C15H10ClFN2O/c16-9-5-6-13-11(7-9)15(18-8-14(20)19-13)10-3-1-2-4-12(10)17/h1-7H,8H2,(H,19,20)

Sinónimos: CM 7116,NCGC00247051-02,Descarbethoxyloflazepate,CHEBI:135197,BRN 0754061,AMY15326,MFCD00083443,Norflurazepam,2886-65-9,(E)-7-Chloro-5-(2-fluorophenyl)-1H-benzo[e][1,4]diazepin-2(3H)-one,7-chloro-5-(2-fluorophenyl)-1,3-dihydro-1,4-benzodiazepin-2-one,7-chloro-5-(2-fluorophenyl)-2,3-dihydro-1H-1,4-benzodiazepin-2-one,Ro 5-3367,7-chloro-1,3-dihydro-5-(2-fluorophenyl)-2H-1,4-benzodiazepine-2-one,5-(2-Fluorophenyl)-7-chloro-1,4-benzodiazepin-2-one,Desalkylflurazepam,7-Chloro-5-(2-fluoro-phenyl)-1,3-dihydro-2H-1,4-benzodiazepin-2-one,7-Chloro-5-(2-fluorophenyl)-1,3-dihydro-1,4-benzodiazepin-2one,Dealkylflurazepam,Norfludiazepam; Norflurazepam,Flurazepam-M (Desalkyl),ZINC1433338,BDBM50408014,F21326,SCH-17514,7-Chloro-5-(2-fluorophenyl)-1H-benzo-[e][1,4]diazepin-2(3H)-one,X9U41NXR6M,FT-0634532,nor-Flurazepam,UNII-X9U41NXR6M,Norflutoprazepam,7-Chloro-5-(2-fluorophenyl)-1,3-dihydro-2H-1,4-benzodiazepin-2-one,CM-7116,Ro-05-3367,Norfludiazepam,7-Chloro-5-(o-fluorophenyl)-1,3-dihydro-1,4-benzodiazepin-2-one,N-Desalkylflutoprazepam,SCHEMBL5177297,Opera_ID_747,n-desalkylflurazepam,7-chloro-1,3-dihydro-5-(2-fluorophenyl)-2H-1,4-benzodiazepin-2-one,7-Chloro-5-(2-fluorophenyl)-1H-benzo[e][1,4]diazepin-2(3H)-one,2H-1,4-BENZODIAZEPIN-2-ONE, 1,3-DIHYDRO-7-CHLORO-5-(2-FLUOROPHENYL)-,MIDAZOLAM IMPURITY F [EP IMPURITY],HMS3371H16,N-Desalkylflurazepam,norflurazepam,7-chloro-1,3-dihydro-5 -(2-fluorophenyl)-2H-1,4-benzodiazepin-2-one,Ro-053367,J13.722G,AC-11173,NCGC00247051-01,MLS000028851,EINECS 220-748-3,AKOS015854231,W-107024,DS-18402,7-chloro-5-(2-fluorophenyl)- 1,4-Benzodiazepin-2-one,DB-047480,Sch 17514,CHEMBL974,MLS001146946,Norfludiazepam, analytical standard,N-Desalkyl-2-oxoquazepam,2H-1,4-Benzodiazepin-2-one, 7-chloro-5-(2-fluorophenyl)-1,3-dihydro-,SMR000058397,HMS2236J07,DTXSID30183057,Q27293739,5-24-04-00319 (Beilstein Handbook Reference),TL8002277,2H-1,4-Benzodiazepin-2-one, 7-chloro-5-(o-fluorophenyl)-1,3-dihydro-

Market name: norflurazepam

Estimated data

Solubilidad: -4.892 (log(S) in mol/L prediction using SolTranNet)

Blood Brain Barrier Permeability: No (prediction using frontiersin.org)

Addictivity Prediction: 57.5% (prediction based on www.mdpi.com)

Similitudes

The following is a set of comparisons to understand the properties of this compound. This is still higly experimental and is still under active development. Please refer to our series of blog posts to fully understand our approach and its limitations. This information is for informational purposes only and should not be construed as medical advice.